Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Phenotyping of Heart Failure with Biomarkers: Current and Future Perspectives.

Current heart failure reports - 1 Apr 2017

Senthong Vichai, Kirsop Jennifer L, Tang W H Wilson

Abstract excerpt

INTRODUCTION: Heart failure (HF) is a complex clinical syndrome with diverse risk factors and etiologies, differing underlying pathophysiology, and large phenotypic heterogeneity. RECENT FINDINGS: Advances in imaging techniques coupled with clinical trials that targeted only in those with impaired left ventricular ejection fraction (LVEF) have largely shaped the current management strategy for HF that focuses...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Forecasting
Share to Heart Failure

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Stroke Volume

Share to Ventricular Dysfunction, Left

Share to Ventricular Function, Left

Source

Open in PubMed Open full text

Identifiers

PMID: 28205040
DOI: 10.1007/s11897-017-0321-4
PMCID: PMC5357587

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Phenotyping of Heart Failure with Biomarkers: Current and Future Perspectives.PMID 28205040Read ↗

Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use.Semantic proximity Read ↗

Genetic Biomarkers in Heart Failure: From Gene Panels to Polygenic Risk Scores.Semantic proximity Read ↗

Molecular Diagnostics in Heart Failure: From Biomarkers to Personalized MedicineSemantic proximity Read ↗

Clinical Phenogroups in Heart Failure with Preserved Ejection Fraction.Semantic proximity Read ↗

The HeartMagic prospective observational study protocol – characterizing subtypes of heart failure with preserved ejection fractionSemantic proximity Read ↗

The future of heart failure with preserved ejection fraction : Deep phenotyping for targeted therapeutics.Semantic proximity Read ↗

The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update.Semantic proximity Read ↗

Key Phenotypes of Heart Failure with Preserved Ejection Fraction: Pathophysiologic Mechanisms and Potential Treatment Strategies.Semantic proximity Read ↗

Defining the Phenotypes for Heart Failure With Preserved Ejection Fraction.Semantic proximity Read ↗

Phenotypic spectrum of heart failure with preserved ejection fraction.Semantic proximity Read ↗

Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension.Semantic proximity Read ↗

Rationale and Design of the HeartShare/AMP-HF Deep Phenotyping Study to Improve Understanding of Heart Failure With Preserved Ejection Fraction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.